Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 8 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Brugia malayi | Stress-activated protein kinase jnk-1 | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Schistosoma japonicum | IPR000164,Histone H3;IPR009072,Histone-fold,domain-containing | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Echinococcus granulosus | c-Jun N-terminal kinases | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Schistosoma japonicum | ko:K04440 c-Jun N-terminal kinase, putative | Get druggable targets OG5_129677 | All targets in OG5_129677 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.008 | 0.2804 | 0.2804 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0475 | 0.0475 |
Brugia malayi | cyclic AMP-response element binding protein 1 gamma 1, putative | 0.0237 | 0.8496 | 0.8496 |
Echinococcus granulosus | death domain containing protein | 0.0016 | 0.0475 | 0.0475 |
Schistosoma mansoni | netrin receptor unc5 | 0.0016 | 0.0475 | 0.0475 |
Echinococcus multilocularis | netrin receptor unc 5 | 0.0016 | 0.0475 | 0.0475 |
Schistosoma mansoni | ankyrin 23/unc44 | 0.0016 | 0.0475 | 0.0475 |
Echinococcus multilocularis | ankyrin repeat and death domain containing protein | 0.0016 | 0.0475 | 0.0475 |
Echinococcus granulosus | Ankyrin | 0.0016 | 0.0479 | 0.0479 |
Brugia malayi | Uncoordinated protein 44 | 0.0016 | 0.0475 | 0.0475 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0278 | 1 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0016 | 0.0475 | 0.0475 |
Echinococcus multilocularis | Ankyrin | 0.0016 | 0.0479 | 0.0479 |
Brugia malayi | Protein kinase domain containing protein | 0.0016 | 0.0495 | 0.0495 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0278 | 1 | 1 |
Onchocerca volvulus | Netrin receptor homolog | 0.0016 | 0.0475 | 0.0559 |
Onchocerca volvulus | 0.0237 | 0.8496 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 0.8496 | 0.8496 |
Echinococcus granulosus | ankyrin repeat and death domain containing protein | 0.0016 | 0.0475 | 0.0475 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0479 | 0.0479 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0016 | 0.0475 | 0.0475 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.008 | 0.2804 | 0.2804 |
Echinococcus granulosus | netrin receptor unc 5 | 0.0016 | 0.0475 | 0.0475 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0475 | 0.0475 |
Brugia malayi | Death domain containing protein | 0.0016 | 0.0475 | 0.0475 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0016 | 0.0479 | 0.0479 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0278 | 1 | 1 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0278 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = -6.1 | Negative log of inhibitiory concentration determined against c-Jun N-terminal kinase (Activity reported against the isolated JNK-1 enzyme) | ChEMBL. | 15950471 |
Log IC50 (binding) | = 6.1 | Negative log of inhibitiory concentration determined against c-Jun N-terminal kinase (Activity reported against the isolated JNK-1 enzyme) | ChEMBL. | 15950471 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.